chr10-60196628-G-GAAA

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_020987.5(ANK3):​c.1690-6_1690-4dupTTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0109 in 1,258,284 control chromosomes in the GnomAD database, including 397 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.045 ( 335 hom., cov: 28)
Exomes 𝑓: 0.0069 ( 62 hom. )

Consequence

ANK3
NM_020987.5 splice_region, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.469

Publications

5 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 10-60196628-G-GAAA is Benign according to our data. Variant chr10-60196628-G-GAAA is described in ClinVar as Benign. ClinVar VariationId is 210147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.133 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK3NM_020987.5 linkc.1690-6_1690-4dupTTT splice_region_variant, intron_variant Intron 14 of 43 ENST00000280772.7 NP_066267.2 Q12955-3
ANK3NM_001204404.2 linkc.1639-6_1639-4dupTTT splice_region_variant, intron_variant Intron 14 of 43 NP_001191333.1 Q12955-4
ANK3NM_001320874.2 linkc.1690-6_1690-4dupTTT splice_region_variant, intron_variant Intron 14 of 42 NP_001307803.1
ANK3NM_001204403.2 linkc.1672-6_1672-4dupTTT splice_region_variant, intron_variant Intron 15 of 43 NP_001191332.1 Q12955-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK3ENST00000280772.7 linkc.1690-4_1690-3insTTT splice_region_variant, intron_variant Intron 14 of 43 1 NM_020987.5 ENSP00000280772.1 Q12955-3

Frequencies

GnomAD3 genomes
AF:
0.0446
AC:
5937
AN:
132968
Hom.:
334
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.136
Gnomad AMI
AF:
0.00256
Gnomad AMR
AF:
0.0268
Gnomad ASJ
AF:
0.00595
Gnomad EAS
AF:
0.0606
Gnomad SAS
AF:
0.00496
Gnomad FIN
AF:
0.00313
Gnomad MID
AF:
0.0310
Gnomad NFE
AF:
0.00231
Gnomad OTH
AF:
0.0406
GnomAD2 exomes
AF:
0.0225
AC:
2550
AN:
113098
AF XY:
0.0190
show subpopulations
Gnomad AFR exome
AF:
0.129
Gnomad AMR exome
AF:
0.0160
Gnomad ASJ exome
AF:
0.00957
Gnomad EAS exome
AF:
0.0675
Gnomad FIN exome
AF:
0.00302
Gnomad NFE exome
AF:
0.00318
Gnomad OTH exome
AF:
0.0223
GnomAD4 exome
AF:
0.00689
AC:
7750
AN:
1125286
Hom.:
62
Cov.:
21
AF XY:
0.00664
AC XY:
3749
AN XY:
564232
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.111
AC:
2854
AN:
25692
American (AMR)
AF:
0.0109
AC:
357
AN:
32746
Ashkenazi Jewish (ASJ)
AF:
0.00686
AC:
144
AN:
20978
East Asian (EAS)
AF:
0.0633
AC:
2098
AN:
33128
South Asian (SAS)
AF:
0.00429
AC:
289
AN:
67400
European-Finnish (FIN)
AF:
0.00212
AC:
79
AN:
37314
Middle Eastern (MID)
AF:
0.0292
AC:
136
AN:
4660
European-Non Finnish (NFE)
AF:
0.00135
AC:
1152
AN:
856220
Other (OTH)
AF:
0.0136
AC:
641
AN:
47148
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.369
Heterozygous variant carriers
0
358
717
1075
1434
1792
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
152
304
456
608
760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0447
AC:
5951
AN:
132998
Hom.:
335
Cov.:
28
AF XY:
0.0444
AC XY:
2832
AN XY:
63800
show subpopulations
African (AFR)
AF:
0.136
AC:
5033
AN:
37038
American (AMR)
AF:
0.0268
AC:
349
AN:
13036
Ashkenazi Jewish (ASJ)
AF:
0.00595
AC:
19
AN:
3192
East Asian (EAS)
AF:
0.0605
AC:
283
AN:
4674
South Asian (SAS)
AF:
0.00499
AC:
21
AN:
4208
European-Finnish (FIN)
AF:
0.00313
AC:
22
AN:
7022
Middle Eastern (MID)
AF:
0.0336
AC:
9
AN:
268
European-Non Finnish (NFE)
AF:
0.00231
AC:
141
AN:
60988
Other (OTH)
AF:
0.0402
AC:
72
AN:
1790
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
207
414
622
829
1036
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00379
Hom.:
21

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
May 12, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 18, 2017
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.47
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34796699; hg19: chr10-61956386; API